{
    "nct_id": "NCT03785249",
    "official_title": "A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients With Advanced Solid Tumors With KRAS G12C Mutation KRYSTAL-1",
    "inclusion_criteria": "* Histologically confirmed diagnosis of a solid tumor malignancy with KRAS G12C mutation\n* Unresectable or metastatic disease\n* Standard treatment is not available or patient declines; first-line treatment for NSCLC for certain cohorts\n* Adequate organ function\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* History of intestinal disease or major gastric surgery or inability to swallow oral medications\n* Other active cancer",
    "miscellaneous_criteria": ""
}